国际皮肤性病学杂志    2002 28 (1): 28-31   ISSN: 2096-5540  CN: 32-1880/R   B7分子在系统性红斑狼疮发病和治疗中的意义 沈斌, 许冰 浙江大学医学院附属第一医院皮肤科 杭州 310003 收稿日期 2001-05-21  修回日期 null  网络版发布日期 null 参考文献  [1] Sfikakis PP, Oglesby R, Sfi kakis P, et al. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol, 1994,96(1):8-14. [2] Folzenlogen D, Hofer MF, Leung DY, et al. Analysis of CD80 and CD86expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol, 1997,83(3): 199-204. [3] Kovacs B, Thomas DE, Tsokos GC. Elevated in vivo expression of the costimulatory molecule B7-BB1 (CD80) on antigen presenting cells from a patient with SLE. Clin Exp Rheumatol, 1996,14(6): 695-697. [4] Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest, 1996, 98 (3):826-837. [5] Bijl M, Horst G, Limburg PC, et al. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis, 2001,60(5): 523-526. [6] Takasaki Y, Abe K, Tokano Y, et al. The expression of LFA-1, ICAM1, CD80 and CD86 molecules in lupus patients. implication for immunotherapy. Intern Med, 1999,38(2): 175-177. [7] Takasaki Y, Ogaki M, Abe K, et al. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus. J Rheumatol, 1998,25(6): 1085-1091. [8] Abe K, Takasaki Y, Ushiyama C, et al. Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus. J Clin Immunol, 1999,19(1):58-66. [9] Sfiikakis PP, Via CS. Expression of CD28, CTLA4, CD80, and CD86molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy. Clin Immunol Immunopathol, 1997,83(3): 195-198. [10] Denfeld RW, Kind P, Sontheimer RD,et al. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum, 1997,40(5): 814-821. [11] Tsokos GC. Lymphocytes, cytokines, inflammation, and immune trafficking. Curr Opin Rheumatol, 1996,8(5): 395-402. [12] Tsokos GC, Kovacs B, Sfikakis PP, et al. Defective antigen-presenting cell function in patients with systemic lupus erythematosus. Arthritis Rheum, 1996,39(4): 600-609. [13] Liu MF, Li JS, Weng TH, et al. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus. Scand J Immunol, 1999,49(1): 82-87. [14] Scheinecker C, Zwolfer B, Koller M, et al. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.Arthritis Rheum, 2001,44(4): 856-865. [15] Garcia-Cozar FJ, Molina IJ, Cuadrado MJ, et al. Defective B7expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immumol, 1996,104(1): 72-79. [16] Lauwerys BR, Garot N, Renauld JC, et al. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum, 2000,43(9): 1976-1981. [17] Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science, 1994,265(5176): 1225-1227. [18] Daikh DI, Finck BK, Linsley PS, et al. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39costimulation pathways. J Immunol, 1997,159 (7): 31 04-3108. [19] Nakajima A, Azuma M, Kodera S, et al. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.Eur J Immunol, 1995,25(11): 3060-3069. [20] Liang B, Gee R J, Kashgarian MJ, et al. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7. 1/B7.2 or in the presence of anti-b7. 1/B7.2 blocking antibodies. J Immunol, 1999,163(4): 2322-2329. [21] Daikh DI, Wofsy D. Effects of anti-B7monoclonal antibodies on humoral immune responses. J Autoimmun, 1999,12(2): 101-108. [22] Kinoshita K, Tesch G, Schwarting A, et al. Costimulation by B7-1 and B7-2 is required for autoinmune disease in MRL-Faslpr mice.J Immunol,2000,164(11): 6046-6056. [23] Liang B, Kashgarian MJ, Sharpe AH, et al. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J Immunol, 2000,165(6): 3436-3443. 通讯作者: